Skip to main content

Advertisement

SpringerLink
Log in

Genetic and Syndromic Causes of Obesity and its Management

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of this article is to provide an in depth review of the rare genetic and syndromic forms of childhood obesity. The authors demonstrate the complexity and inter-relationships of the leptin-melanocortin signaling pathway and its central nervous system and systemic effects. Authors highlight the clinical distinctive features of genetic/syndromic causes for childhood obesity, in particular, relative shorter height to their genetic potential, developmental challenges and in some instances, ophthalmological and retina changes. They outline specific genetic testing and treatment options available for these conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Farooqi S. Insights from the genetics of severe childhood obesity. Horm Res. 2007;68:5–7. ed. 2007;356:237–47.

  2. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356:237–47.

  3. Wabitsch M, Funcke JB, Lennerz B, et al. Biologically inactive leptin and early-onset extreme obesity. N Engl J Med. 2015;372:48–54.

    Article  PubMed  Google Scholar 

  4. Wabitsch M, Funcke JB, von Schnurbein J, et al. Severe early-onset obesity due to bioinactive leptin caused by a p.N103k mutation in the leptin gene. J Clin Endocrinol Metab. 2015;100:3227–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Abaci A, Catli G, Bayram E, et al. A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: Rohhadnet syndrome. Endocr Pract. 2013;19:e12–6.

    Article  PubMed  Google Scholar 

  6. Jacobson P, Ukkola O, Rankinen T, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the swedish obese subjects, the heritage family study, and a memphis cohort. J Clin Endocrinol Metab. 2002;87:4442–6.

    Article  CAS  PubMed  Google Scholar 

  7. Vollbach H, Brandt S, Lahr G, et al. Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort. Int J Obes. 2017;41:13–22.

    Article  CAS  Google Scholar 

  8. Hinney A, Volckmar AL, Knoll N. Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci. 2013;114:147–91.

    Article  CAS  PubMed  Google Scholar 

  9. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348:1085–95.

    Article  CAS  PubMed  Google Scholar 

  10. Paolini B, Maltese PE, Del Ciondolo I, et al. Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity. Genet Mol Res. 2016;15(3). https://doi.org/10.4238/gmr.15038718.

  11. Hainerova IA, Lebl J. Treatment options for children with monogenic forms of obesity. World Rev Nutr Diet. 2013;106:105–12.

    PubMed  Google Scholar 

  12. Wardlaw SL. Hypothalamic proopiomelanocortin processing and the regulation of energy balance. Eur J Pharmacol. 2011;660:213–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by pomc mutations in humans. Nat Genet. 1998;19:155–7.

    Article  CAS  PubMed  Google Scholar 

  14. Kuehnen P, Mischke M, Wiegand S, et al. An alu element-associated hypermethylation variant of the pomc gene is associated with childhood obesity. PLoS Genet. 2012;8:e1002543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kuhnen P, Handke D, Waterland RA, et al. Interindividual variation in DNA methylation at a putative pomc metastable epiallele is associated with obesity. Cell Metab. 2016;24:502–9.

    Article  PubMed  Google Scholar 

  16. Kuhnen P, Clement K, Wiegand S, et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N Engl J Med. 2016;375:240–6.

    Article  PubMed  Google Scholar 

  17. Loffler D, Behrendt S, Creemers JW, et al. Functional and clinical relevance of novel and known pcsk1 variants for childhood obesity and glucose metabolism. Mol Metab. 2017;6:295–305.

    Article  PubMed  Google Scholar 

  18. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303–6.

    Article  CAS  PubMed  Google Scholar 

  19. Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Mechanisms of obesity in Prader-Willi syndrome. Pediatr Obes. 2016; https://doi.org/10.1111/ijpo.12177.

  20. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402.

  21. Driscoll DJ, Miller JL, Schwartz S, Cassidy SB. Prader-Willi syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean, LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993-2017.

  22. Ize-Ludlow D, Gray JA, Sperling MA, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics. 2007;120:e179–88.

    Article  PubMed  Google Scholar 

  23. Chew HB, Ngu LH, Keng WT. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (rohhad): a case with additional features and review of the literature. BMJ Case Rep. 2011;2011.

  24. Chandrakantan A, Poulton TJ. Anesthetic considerations for rapid-onset obesity, hypoventilation, hypothalamic dysfunction, and autonomic dysfunction (rohhad) syndrome in children. Paediatr Anaesth. 2013;23:28–32.

    Article  PubMed  Google Scholar 

  25. Sumanasena SP, de Silva S, Perera I, Sudeen A, Wasala R. Rapid onset obesity, hypoventilation, hypothalamic, autonomic and thermal dysregulation, and neural tumour (rohhadnet) syndrome presenting with cushing syndrome. Ceylon Med J. 2012;57:47–8.

    Article  CAS  PubMed  Google Scholar 

  26. Barclay SF, Rand CM, Borch LA, et al. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (rohhad): exome sequencing of trios, monozygotic twins and tumours. Orphanet J Rare Dis. 2015;10:103.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Barclay SF, Rand CM, Gray PA, et al. Absence of mutations in hcrt, hcrtr1 and hcrtr2 in patients with rohhad. Respir Physiol Neurobiol. 2016;221:59–63.

    Article  CAS  PubMed  Google Scholar 

  28. Alvarez-Satta M, Castro-Sanchez S, Valverde D. Alstrom syndrome: current perspectives. Appl Clin Genet. 2015;8:171–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Nikopoulos K, Butt GU, Farinelli P, et al. A large multiexonic genomic deletion within the ALMS1 gene causes Alstrom syndrome in a consanguineous Pakistani family. Clin Genet. 2015; https://doi.org/10.1111/cge.12645.

  30. Das Bhowmik A, Gupta N, Dalal A, Kabra M. Whole exome sequencing identifies a homozygous nonsense variation in ALMS1 gene in a patient with syndromic obesity. Obes Res Clin Pract. 2017;11:241–6.

    Article  PubMed  Google Scholar 

  31. Forsythe E, Beales PL. Bardet-biedl syndrome. Eur J Hum Genet. 2013;21:8–13.

    Article  CAS  PubMed  Google Scholar 

  32. Seo S, Guo DF, Bugge K, Morgan DA, Rahmouni K, Sheffield VC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18:1323–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Gruters-Kieslich A, Reyes M, Sharma A, et al. Early-onset obesity: unrecognized first evidence for GNAS mutations and methylation changes. J Clin Endocrinol Metab. 2017;102:2670–7.

  34. Mason K, Page L, Balikcioglu PG. Screening for hormonal, monogenic, and syndromic disorders in obese infants and children. Pediatr Ann. 2014;43:e218–24.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ali O, Cerjak D, Kent JW Jr, et al. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity. Epigenetics. 2016;11:699–707.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879–84.

    Article  CAS  PubMed  Google Scholar 

  37. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:709–57.

    Article  PubMed  Google Scholar 

  38. Yanovski JA, Krakoff J, Salaita CG, et al. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes. 2011;60:477–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kendall D, Vail A, Amin R, et al. Metformin in obese children and adolescents: the moca trial. J Clin Endocrinol Metab. 2013;98:322–9.

    Article  CAS  PubMed  Google Scholar 

  40. Maahs D, de Serna DG, Kolotkin RL, et al. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract. 2006;12:18–28.

    Article  PubMed  Google Scholar 

  41. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293:2873–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Contributions

IHK drafted the manuscript and developed it ready for submission. IHK is the corresponding author. CR provided oversight of manuscript editing and developed the included figure and Table 1. Senior author. Dr. Catherine Pihoker, Professor of Pediatrics / University of Washington, Division of Endocrinology and Diabetes, Seattle Children’s Hospital will act as guarantor for this paper.

Author information

Authors and Affiliations

  1. Division of Endocrinology and Diabetes, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA

    Ildiko H. Koves & Christian Roth

  2. Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, WA, USA

    Christian Roth

Authors
  1. Ildiko H. Koves
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ildiko H. Koves.

Ethics declarations

Conflict of Interest

None.

Source of Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koves, I.H., Roth, C. Genetic and Syndromic Causes of Obesity and its Management. Indian J Pediatr 85, 478–485 (2018). https://doi.org/10.1007/s12098-017-2502-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-017-2502-2

Keywords

Search

Navigation